Traditional Chinese medicine composition for treating coronary heart disease and angina pectoris as well as preparation method and application of traditional Chinese medicine composition
By developing a traditional Chinese medicine composition containing ingredients such as ginseng, raw dragon bones, black snakes, etc., the problem of poor efficacy in treating coronary heart disease and angina pectoris in the prior art has been solved, and warming yang and replenishing qi, relieving phlegm and promoting blood circulation, calming the heart and restoring the pulse, and achieving warming yang and nourishing the heart and restoring the pulse The effect and simplify the preparation process, providing a variety of dosage form options.
Patent Information
- Application Number
- CN202411202751.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-29
- Publication Date
- 2024-11-26
AI Technical Summary
The prior art has poor drug treatment effect in the treatment of coronary heart disease and angina pectoris, and long-term use can easily cause adverse drug reactions. The traditional Chinese medicine prescription for promoting blood circulation and removing blood stasis is limited in its efficacy.
A traditional Chinese medicine composition has been developed, including ginseng, raw dragon bone, black snake, Ophiopogon japonicus, red peony root, Chuanxiong, Pinellia qi, Trichosanthes kirilowii, Poria cocos, Coptis chinensis and licorice, which is prepared into a concentrated solution by decoction and concentration. , used to prepare granules, tablets, oral liquids or capsules for the treatment of coronary heart disease and angina pectoris, which have the effects of warming yang and replenishing qi, relieving phlegm and promoting blood circulation, calming heart and restoring meridians.
This traditional Chinese medicine composition has the effects of replenishing heart qi, promoting heart blood, eliminating heart turbidity, benefiting heart meridians, and calming heart spirits. It significantly improves the therapeutic effect of coronary heart disease and angina pectoris, simplifies the preparation process, and provides a variety of dosage form choices, which is significantly better than traditional Traditional Chinese medicine prescription.
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to a traditional Chinese medicine composition for treating coronary heart disease and angina pectoris, and a preparation method and use thereof. Background Art
[0002] Coronary heart disease is a heart disease caused by myocardial ischemia, hypoxia or necrosis due to stenosis or occlusion of the lumen caused by coronary atherosclerosis, so it is also called ischemic heart disease. Modern medical clinical investigations and studies have shown that myocardial tissue hypoxia and ischemia due to insufficient blood supply to the coronary arteries is the direct cause of the disease. At the same time, emotional excitement, physical labor, cold and full meals in daily life can induce the disease. When coronary heart disease and angina pectoris occur, the main clinical manifestations are paroxysmal chest tightness and chest pain in the precordial area. Some patients also experience radiating pain in the left upper limb or left back during angina pectoris attacks. Most patients with coronary heart disease and angina pectoris are middle-aged and elderly people. If not treated in time, it will cause myocardial infarction or sudden death of the patient, seriously threatening the health of the people.
[0003] At present, Western medicine mainly uses anticoagulant, lipid-lowering, and coronary dilation drugs in clinical treatment, including drugs to relieve angina (e.g., nitrates), antithrombotic drugs, drugs to reduce myocardial oxygen consumption (e.g., beta-blockers), and lipid-regulating plaque-stabilizing drugs (e.g., statins). For severe patients, interventional treatment (e.g., intravascular balloon angioplasty and stent implantation) and surgical coronary artery bypass grafting are adopted clinically. Although Western medicine can relieve the patient's clinical symptoms in a relatively short period of time, the long-term treatment effect is poor, and long-term use is prone to cause multiple adverse drug reactions.
[0004] Traditional Chinese medicine has made great contributions to the treatment of coronary heart disease and angina pectoris. Traditional Chinese medicine defines coronary heart disease as a category of "chest pain and heartache". Traditional Chinese medicine believes that insufficient heart and kidney yang qi leads to weak chest yang; internal injuries caused by the seven emotions lead to qi stagnation; improper diet and excessive fatigue damage the spleen and stomach, causing phlegm and turbidity; external invasion of cold evil leads to cold stagnation in the heart meridian. The above pathogenic factors block the heart meridian and cause chest pain and heartache. It is generally believed that the pathogenesis is mainly based on weak heart and kidney, with yang qi deficiency as the main cause, long-term illness damages yang and yin, and both yin and yang are deficient; qi stagnation, blood stasis, cold stagnation, and phlegm are the symptoms. Conventional prescriptions for the treatment of coronary heart disease are mostly based on promoting blood circulation, removing blood stasis and removing phlegm, but the actual treatment effect of simple prescriptions for promoting blood circulation, removing blood stasis and removing phlegm is not particularly ideal.
[0005] In view of this, the development of new Chinese medicine compositions for treating coronary heart disease and angina pectoris and their preparation methods and applications have important clinical significance and commercial value. Summary of the invention
[0006] In view of the shortcomings and defects of the prior art, the present invention provides a Chinese medicine composition for treating coronary heart disease and angina pectoris, and a preparation method and use thereof. The Chinese medicine composition of the present invention has a unique formula and significant effect, and the various medicinal flavors in the formula produce a synergistic effect and the preparation method is simple.
[0007] The purpose of the present invention can be achieved through the following technical solutions:
[0008] In the first aspect, the present invention provides a traditional Chinese medicine composition for treating coronary heart disease and angina pectoris, wherein the traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: 10-40 parts of ginseng, 10-40 parts of raw dragon bones, 5-30 parts of garcinia, 5-30 parts of ophiopogon, 5-30 parts of red peony root, 5-30 parts of chuanxiong, 5-30 parts of pinellia, 5-20 parts of trichosanthes, 5-20 parts of allium macrostemon, 5-20 parts of poria, 5-20 parts of coptis, and 1-10 parts of liquorice.
[0009] As an optional manner, in the above-mentioned traditional Chinese medicine composition, the traditional Chinese medicine composition is made of the following raw materials in parts by weight: 20-30 parts of ginseng, 20-30 parts of raw dragon bones, 5-20 parts of black snake, 5-20 parts of ophiopogon, 5-20 parts of red peony root, 5-20 parts of chuanxiong, 5-20 parts of pinellia, 5-15 parts of trichosanthes, 5-15 parts of allium macrostemon, 5-15 parts of poria, 5-15 parts of coptis, and 1-8 parts of licorice.
[0010] As an optional method, in the above-mentioned traditional Chinese medicine composition, the traditional Chinese medicine composition is made of the following raw materials in parts by weight: 24 parts of ginseng, 26 parts of raw dragon bones, 18 parts of black-necked snakes, 18 parts of ophiopogon japonicus, 18 parts of red peony root, 18 parts of ligusticum chuanxiong, 18 parts of pinellia tuber, 12 parts of trichosanthes, 12 parts of allium macrostemon, 12 parts of poria, 12 parts of coptis chinensis, and 6 parts of licorice.
[0011] As an optional manner, in the above-mentioned traditional Chinese medicine composition, the traditional Chinese medicine composition has the effects of warming yang and invigorating qi, resolving phlegm and activating blood circulation, and calming the heart and restoring the pulse.
[0012] In a second aspect, the present invention provides a method for preparing the Chinese medicine composition of the first aspect, the method comprising the following steps: crushing ginseng, raw dragon bone, black-banded snake, ophiopogon japonicus, red peony root, chuanxiong, pinellia tuber, trichosanthes, allium macrostemon, tuckahoe, coptis root, and liquorice, adding water to decoct, mixing the filtrate, and concentrating to obtain a concentrated solution,
[0013] As an optional manner, in the above preparation method, the decoction is performed twice, and after the first decoction for 1-3 hours, a primary filtrate is obtained by filtering, the filter residue is further decocted with water for 1-3 hours, and a secondary filtrate is obtained by filtering, and the primary filtrate and the secondary filtrate are combined.
[0014] As an optional manner, in the above preparation method, the material-liquid ratio of the first decoction and the second decoction is 1:4, the decoction time of the first decoction and the second decoction is 1.5 hours, and the water used for the first decoction and the second decoction is distilled water; preferably, the concentration is reduced pressure concentration.
[0015] In the third aspect, the present invention provides use of the Chinese medicine composition described in the first aspect or the Chinese medicine composition prepared by the preparation method described in the second aspect in preparing a drug for treating coronary heart disease and angina pectoris.
[0016] As an optional mode, in the above-mentioned use, the dosage form of the drug is granules, tablets, oral liquid or capsules.
[0017] As an optional mode, in the above-mentioned use, the dosage form of the drug is granules.
[0018] Compared with the prior art, the present invention has the following beneficial effects:
[0019] (1) The Chinese medicine composition of the present invention has the effects of invigorating heart qi, promoting heart blood circulation, resolving heart turbidity, benefiting heart pulse, and calming the mind, and is mainly used to treat coronary heart disease and angina pectoris. The Chinese medicine composition of the present invention has a unique formula and significant effect, and the various medicinal flavors in the formula produce a synergistic effect.
[0020] (2) The Chinese medicine composition of the present invention is based on the traditional Chinese medicine formula, uses modern preparation technology and is deeply optimized. The preparation method is simple, and the Chinese medicine composition of the present invention can be made into various dosage forms such as granules, tablets, oral liquids or capsules. DETAILED DESCRIPTION
[0021] The efficacy and main treatment of each medicinal ingredient in the Chinese medicine composition of the present invention are as follows:
[0022] "Ginseng" is the dried root of Panax ginseng CAMey, a plant of the Araliaceae family. It is mild in nature, sweet, slightly bitter, and slightly warm in taste. It enters the spleen and lung meridians. It greatly replenishes vital energy, restores the pulse and consolidates the body, replenishes the spleen and lungs, promotes the production of body fluids and quenches thirst, and calms the mind and improves intelligence. The fleshy root of ginseng is a tonic medicine for all symptoms of deficiency of qi, blood, and body fluids, such as fatigue, loss of appetite, fatigue, nausea and vomiting, loose stools, cough and shortness of breath, spontaneous sweating, palpitations, forgetfulness, dizziness and headaches, impotence, frequent urination, thirst, metrorrhagia in women, slow fright in children, and long-term weakness.
[0023] "Ophiopogon" is the dried root of Ophiopogon japonicus (Thunb.) Ker-Gawl., a plant of the Liliaceae family. It is sweet, slightly bitter, and slightly cold. It enters the heart, lung, and stomach meridians. It nourishes yin and produces body fluid, moistens the lungs and clears the heart. It is used for dry cough due to lung dryness, cough due to consumptive tuberculosis, thirst due to loss of body fluid, restlessness and insomnia, internal heat and thirst, dry intestines and constipation, and diphtheria.
[0024] "Trichosanthes klrllowll Maxim." is the mature fruit of the plant Trichosanthes klrllowll Maxim. of the Cucurbitaceae family. It is cold in nature, sweet and slightly bitter in taste. It clears away heat and eliminates phlegm, relieves chest tightness and resolves stagnation, moistens and lubricates the intestines. It is a heat-clearing and phlegm-clearing medicine under the category of expectorant, cough-relieving and asthma-relieving medicine. It is used to treat lung-heat cough, turbid yellow and thick phlegm, chest pain, chest congestion, breast abscess, lung abscess, intestinal abscess swelling and pain, and constipation. It has the functions of resisting hypoxia, myocardial ischemia, arrhythmia, and platelet aggregation.
[0025] Xiebai is the bulb of Allium macrostemon Bge. or Allium chinense G. Don, a plant of the Liliaceae family. It is warm in nature, pungent and bitter in taste. It can promote yang and dissipate stagnation, and promote qi and relieve stagnation. It is a qi-regulating drug. It can treat chest pain, cough and asthma due to phlegm and fluid retention, and heaviness after diarrhea. For external use, mash it and apply it or apply the mashed juice.
[0026] "Red peony" is the dried root of Paeonia lactiflora Pall. or Paeonia veitchii Lynch, Ranunculaceae. It tastes bitter and slightly cold. It enters the liver meridian. It clears away heat and cools blood, dissipates blood stasis and relieves pain. It is used for fever-induced rashes, hematemesis and epistaxis, red and swollen eyes, liver depression and hypochondriac pain, amenorrhea and dysmenorrhea, abdominal pain due to lumps, injuries from falls, carbuncles, ulcers and sores.
[0027] "Chuanxiong" is the rhizome of the plant Chuanxiong Ligusticum chuam.iong Hort. of the Umbelliferae family. It is warm in nature and pungent in taste. It can promote blood circulation and qi, dispel wind and relieve pain. It is a blood-activating and analgesic drug under the category of blood-activating and stasis-removing drugs. It is used for chest pain, heart pain, chest and flank pain, swelling and pain caused by falls, irregular menstruation, amenorrhea and dysmenorrhea, abdominal pain caused by urinary tract infections, headache, and rheumatic pain.
[0028] "Poria" is the dried sclerotium of the fungus Poria cocos (Schw.) Wolf of the Polyporaceae family. It is sweet, light and neutral. It can dissipate dampness and promote diuresis; invigorate the spleen and stomach; soothe the mind and calm the nerves. It can also treat urination problems; edema; cough and reverse phlegm; vomiting; poor appetite due to spleen deficiency; diarrhea; palpitations and restlessness; insomnia and forgetfulness; and turbid spermatorrhea.
[0029] "Dragon bone" is the fossil of bones of ancient mammals such as elephants, rhinoceroses, three-toed horses, etc. It is sweet, astringent, and neutral. It can astringe qi and expel dampness, stop night sweats, calm the mind, astringe semen and stop bleeding. It can treat night sweats, nocturnal emission, spermatorrhea, intestinal wind and blood, diarrhea, vomiting and bleeding, and metrorrhagia. It can be used externally to heal wounds. It can be made into decoctions or pills and powders. Grind it into powder and apply it to the affected area for external use.
[0030] "Coptis chinensis" is the dried rhizome of Coptis chinensis Franch., Coptisdeltoidea CYChenget Hsiao or Coptis teeta Wall. of the Ranunculaceae family. It tastes bitter and cold. It enters the heart, spleen, stomach, liver, gallbladder and large intestine meridians. It clears away heat and dries dampness, and clears away fire and detoxifies. It is used for damp-heat fullness, vomiting and acid regurgitation, diarrhea, jaundice, high fever and coma, hyperactivity of heart fire, restlessness and insomnia, vomiting and bleeding due to blood heat, red eyes, toothache, thirst, carbuncle and furuncle; it is used externally to treat eczema, wet sores, and pus discharge from the ear canal. Wine-boiled Coptis chinensis is good at clearing heat from the upper jiao. It is used for red eyes and mouth sores. Coptis chinensis with ginger clears the stomach and harmonizes the stomach to stop vomiting. It is used for cold and heat, damp-heat blocking the middle, fullness and vomiting. Coptis chinensis with cornel and rhizome soothes the liver and harmonizes the stomach to stop vomiting. It is used for liver-stomach disharmony and vomiting and acid regurgitation.
[0031] "Pinellia" is the dried tuber of Pinellia ternata (Thunb.) Breit, a plant of the Araceae family. It is pungent, warm, and toxic. It enters the spleen, stomach, and lung meridians. It dries dampness and resolves phlegm, relieves adverse reactions and stops vomiting, and eliminates lumps and resolves nodules. It is used for cough and asthma due to excessive phlegm, dizziness and palpitations due to phlegm and fluid, dizziness due to wind and phlegm, headache due to phlegm syncope, vomiting and nausea, chest and abdominal distension, and plum pit syndrome; it can be used raw for external treatment of carbuncle and phlegm nodules. "Qing Banxia" is mostly used for drying dampness and resolving phlegm, cough and asthma, dizziness and palpitations, etc.
[0032] "Duck-necked snake" is the dried body of Zaocys dhumnades (Cantor), a Colubridae animal. Sweet, neutral. Enters the liver meridian. Expels wind, dredges the meridians, and stops spasms. Used for rheumatism, numbness, cramps, facial paralysis, hemiplegia, convulsions, tetanus, leprosy, scabies, scrofula, and malignant ulcers.
[0033] "Licorice" refers to the root and rhizome of the dicotyledonous plants Leguminosae Glycyrrhiza uralensis Fisch., G.inflata Bat., or G.glabra L. Licorice is mild in nature, sweet in taste, and belongs to the twelve meridians. It has pharmacological effects such as detoxification, expectoration, analgesia, antispasmodic and even anti-cancer. In traditional Chinese medicine, licorice nourishes the spleen and replenishes qi, nourishes coughs and moistens the lungs, relieves urgency and detoxifies, and harmonizes hundreds of medicines. Clinical application is divided into "raw use" and "honey-roasted". Raw use is mainly used to treat sore throat, painful carbuncle, gastrointestinal ulcers, and detoxification, food poisoning, etc.; honey-roasted use is mainly used to treat spleen and stomach dysfunction, loose stools, fatigue and fever, cough, palpitations, etc.
[0034] The therapeutic principle of the Chinese medicine composition of the present invention is to warm the yang and invigorate the qi, resolve phlegm and activate blood circulation, and calm the heart and restore the pulse. The prescription principle of the Chinese medicine composition of the present invention is as follows: the main medicine: ginseng (greatly replenishing the vital energy), raw dragon bone (calming the heart and calming the nerves and relieving pain); the ministerial medicine: black-striped snake (activating blood circulation and removing blood stasis), ophiopogon (nourishing yin and nourishing the heart), red peony root, chuanxiong (activating blood circulation and promoting qi circulation), pinellia (resolving phlegm and dispersing nodules); the adjuvant medicine: trichosanthes (promoting qi circulation and relieving chest tightness), scutellaria baicalensis (warming the yang and relieving pain), tuckahoe (strengthening the spleen and removing dampness), coptis chinensis (clearing stagnant heat); the guiding medicine: liquorice (tonifying qi and harmonizing various medicines).
[0035] The present invention will be further described with reference to specific embodiments. It should be understood that the specific embodiments described herein are only used to explain the present invention and are not intended to limit the scope of the present invention.
[0036] If no specific techniques or conditions are specified in the examples, the techniques or conditions described in the literature in the field or the product instructions are used. If no manufacturer is specified for the reagents or instruments used, they are all conventional products that can be purchased through regular channels.
[0037] The experimental methods in the following examples are conventional methods unless otherwise specified. The experimental materials used in the following examples are commercially available products unless otherwise specified.
[0038] Preparation Example:
[0039] Embodiment 1:
[0040] A traditional Chinese medicine composition for treating coronary heart disease and angina pectoris, the traditional Chinese medicine composition is prepared from the following raw materials: 24g of ginseng, 26g of raw dragon bone, 18g of black-striped snake, 18g of ophiopogon japonicus, 18g of red peony root, 18g of chuanxiong, 18g of qingbanxia, 12g of trichosanthes, 12g of xiebai, 12g of tuckahoe, 12g of coptis root, and 6g of liquorice.
[0041] The preparation method of the traditional Chinese medicine composition comprises the following steps: crushing ginseng, raw dragon bone, black-striped snake, ophiopogon, red peony root, chuanxiong, pinellia tuber, trichosanthes, allium macrostemon, tuckahoe, coptis root and liquorice, adding water for decoction, decoction twice, the material-liquid ratio of the first decoction and the second decoction is 1:4, the decoction time of the first decoction and the second decoction is 1.5 hours, the water used for the first decoction and the second decoction is distilled water, and after decoction, the filtrate is mixed and concentrated under reduced pressure to obtain 200 mL of concentrated solution.
[0042] Embodiment 2:
[0043] A traditional Chinese medicine composition for treating coronary heart disease and angina pectoris, the traditional Chinese medicine composition is prepared from the following raw materials: 30g of ginseng, 20g of raw dragon bone, 18g of black-striped snake, 18g of ophiopogon japonicus, 18g of red peony root, 18g of chuanxiong, 18g of qingbanxia, 12g of trichosanthes, 12g of xiebai, 12g of tuckahoe, 12g of coptis root, and 6g of liquorice.
[0044] The preparation method of the Chinese medicine composition is the same as that of Example 1.
[0045] Embodiment 3:
[0046] A traditional Chinese medicine composition for treating coronary heart disease and angina pectoris, the traditional Chinese medicine composition is prepared from the following raw materials: 30g of ginseng, 26g of raw dragon bone, 12g of black-striped snake, 18g of ophiopogon japonicus, 18g of red peony root, 18g of chuanxiong, 18g of qingbanxia, 12g of trichosanthes, 12g of xiebai, 12g of tuckahoe, 12g of coptis root, and 6g of liquorice.
[0047] The preparation method of the Chinese medicine composition is the same as that of Example 1.
[0048] Comparative Example 1:
[0049] A traditional Chinese medicine composition is prepared from the following raw materials: 24g of ginseng, 26g of raw dragon bone, 18g of earthworm, 18g of ophiopogon, 18g of red peony root, 18g of ligusticum chuanxiong, 18g of pinellia, 12g of trichosanthes, 12g of allium macrostemon, 12g of tuckahoe, 12g of coptis root, and 6g of liquorice.
[0050] The preparation method of the Chinese medicine composition is the same as that of Example 1.
[0051] Comparative Example 2:
[0052] A traditional Chinese medicine composition is prepared from the following raw materials: 50g of ginseng, 18g of black-necked snake, 18g of ophiopogon japonicus, 18g of red peony root, 18g of ligusticum chuanxiong, 18g of pinellia tuber, 12g of trichosanthes, 12g of allium macrostemon, 12g of tuckahoe, 12g of coptis root, and 6g of liquorice.
[0053] The preparation method of the Chinese medicine composition is the same as that of Example 1.
[0054] Effect embodiment:
[0055] Effect Example 1: Study on the analgesic effect of the Chinese medicine composition of the present invention
[0056] 1. Main Materials and Methods
[0057] 1.1 Animals:
[0058] Male ICR mice, 18-22 g, were provided by Beijing Weitonglihua Experimental Animal Technology Co., Ltd.
[0059] 1.2 Main drugs and reagents:
[0060] The concentrated Chinese medicine compositions prepared in Examples 1-3 and Comparative Examples 1-2 of the present invention. Positive control drug Shensong Yangxin Capsule (components are ginseng, ophiopogon japonicus, cornus officinalis, salvia miltiorrhiza, spiny jujube seeds (fried), parasitic herb, red peony root, earthworm, sweet osmanthus, coptis root, southern schisandra chinensis, dragon bone, invigorating qi and nourishing yin, promoting blood circulation and unblocking collaterals, clearing the heart and calming the mind. It is used to treat ventricular premature beats in coronary heart disease, which belong to qi and yin deficiency, heart meridian stasis syndrome, with symptoms of palpitations, shortness of breath and fatigue, aggravated by movement, chest tightness and pain, insomnia and dreaminess, night sweats, fatigue and laziness), purchased from Beijing Yiling Pharmaceutical Co., Ltd.
[0061] 2. Modeling, grouping, drug administration and testing indicators:
[0062] The electric hot plate was adjusted to (55±0.5)°C, mice were screened, and the time from the mouse entering the hot plate to licking its hind paw was recorded as the pain threshold of the mouse. 56 male mice with a pain threshold within 30s were screened and randomly divided into 7 groups, 8 mice in each group, namely, a blank control group, Example 1-3 groups, Comparative Example 1-2 groups, and a positive control group.
[0063] The dosage of Example 1-3, Comparative Example 1-2 and Positive Control Group was 20 g·kg -1 (The positive control group was adjusted to the same dosage as the experimental group according to the amount of crude drug after deducting the auxiliary materials). The model group was given an equal volume of normal saline, and the gavage volume was 10 mL kg -1 , once a day, for 7 consecutive days.
[0064] One hour after intragastric administration on the 7th day, the mice were placed on a hot plate apparatus to measure the pain threshold of the mice.
[0065] 3. Statistical analysis methods:
[0066] SPSS 23.0 statistical software was used for data analysis. The measurement data were expressed as mean ± standard deviation (mean ± SD). One-way ANOVA was used for comparison among multiple groups. LSD test was used for equal variance test, and Euskal-Wallis method was used for non-parametric test for unequal variance. P < 0.05 was considered statistically significant.
[0067] 4. Experimental results:
[0068] Table 1 shows the analgesic effect of the Chinese medicine composition of the present invention. The experimental results show that compared with the model group, the Example 1-3 groups, the Comparative Example 1-2 groups and the positive control group all have different degrees of analgesic effect, but it can be seen that the analgesic effect of the Comparative Example 1-2 groups and the positive control group is relatively poor. Among them, the analgesic effect of the Example 1 group is the strongest, which is better than the Example 2-3 groups, and significantly better than the positive control group ( ###p<0.001). This result also shows that raw dragon bone and black-banded snake have a certain degree of influence on the analgesic effect of the Chinese medicine composition of the present invention. When the dosage ratio of the above drugs in the formula is reduced, the analgesic effect is slightly reduced.
[0069] The experimental results of Comparative Examples 1-2 show that changing the types of some raw materials in the traditional Chinese medicine composition of the present invention (see Comparative Example 1, in which the black-necked snake in Example 1 is replaced with the medicinal herb Eupolyphaga having similar efficacy) and subtracting some medicinal flavors of the traditional Chinese medicine composition of the present invention (see Comparative Example 2, in which one of the main medicines in Example 1, raw dragon bone, is subtracted) will lead to a significant reduction in the analgesic effect of the traditional Chinese medicine composition of the present invention.
[0070] It can be seen that the types and dosage ratios of the various raw materials used in the Chinese medicine composition of the present invention have a very significant impact on the analgesic effect and therapeutic efficacy of the Chinese medicine composition of the present invention.
[0071] Table 1: Study on the analgesic effect of the Chinese medicine composition of the present invention (mean ± SD, n = 8)
[0072] Group Pain threshold(s) Blank control group 17.24±2.43 Positive control group <![CDATA[20.81±2.65 * , <!-- 5 -->]]> Example 1 Group <![CDATA[25.08±2.94 ***,### ]]> Example 2 Group <![CDATA[23.45±2.18 ***,## ]]> Example 3 Group <![CDATA[24.02±2.27 ***,## ]]> Comparative Example 1 18.76±2.31 Comparative Example 2 <![CDATA[19.23±2.46 * ]]>
[0073] Note: Compared with the blank control group, * p<0.05, *** p<0.001; compared with the positive control group, ## p<0.01, ### p<0.001.
[0074] Example 2: Effect of the Chinese medicine composition of the present invention on the experimental animal model of coronary heart disease
[0075] 1. Main Materials and Methods
[0076] 1.1 Animals:
[0077] Male Sprague Dawley rats, SPF grade, 180g-200g, provided by Beijing Weitonglihua Experimental Animal Technology Co., Ltd.
[0078] 1.2 Main drugs and reagents:
[0079] The concentrated Chinese medicine compositions prepared in Examples 1-3 and Comparative Examples 1-2 of the present invention. The positive control drug Shensong Yangxin Capsule was purchased from Beijing Yiling Pharmaceutical Co., Ltd.
[0080] 2. Modeling, grouping, and drug administration:
[0081] Eight rats were selected from 56 SD rats as a blank control group, and the remaining rats were fed a high-fat diet for 6 consecutive weeks. After 6 weeks, 30 IU / kg of posterior pituitary hormone was injected intraperitoneally at intervals of 24 hours for 3 consecutive times. The ST segment depression and T wave changes of the electrocardiogram were used as the standard to determine that the rat coronary heart disease (CHD) model was successfully prepared. The rats with successful modeling were randomly divided into a model group, Example 1-3 group, Comparative Example 1-2 group and a positive control group.
[0082] The dosage of Example 1-3, Comparative Example 1-2 and Positive Control Group was 10 g·kg -1 (The positive control was adjusted to the same dosage as the experimental group according to the amount of crude drug after deducting the auxiliary materials). The blank control group and the model group were given an equal volume of normal saline, and the gavage volume was 10 mL kg -1 , once a day, for 6 consecutive weeks.
[0083] 3. Detection indicators:
[0084] Determination of cardiac troponin T (cTnT), creatine kinase isoenzyme (CK-MB), and lactate dehydrogenase (LDH) levels in rat aortic serum: After 6 weeks of administration, the rats were opened to expose the abdominal aorta, and 3-4 mL of blood was collected. The upper serum was obtained by centrifugation, and the levels of cTnT, CK-MB, and LDH in the rat aortic serum were detected.
[0085] 4. Statistical analysis methods:
[0086] SPSS 23.0 statistical software was used for data analysis. The measurement data were expressed as mean ± standard deviation (mean ± SD). One-way ANOVA was used for comparison among multiple groups. LSD test was used for equal variance test, and Euskal-Wallis method was used for non-parametric test for unequal variance. P < 0.05 was considered statistically significant.
[0087] 5. Experimental results:
[0088] Table 2 shows the levels of cTnT, CK-MB, and LDH in rat aortic serum. These three detection indicators are markers of rat myocardial injury.
[0089] The experimental results show that compared with the model group, the Example 1-3 groups, the Comparative Example 1-2 groups and the positive control group all have different degrees of reducing the levels of cTnT, CK-MB and LDH in rat serum, but it can be seen that the above effects of the Comparative Example 1-2 groups and the positive control group are relatively poor. Among them, the Example 1 group has the strongest effect on reducing cTnT, CK-MB and LDH in rat serum, which is better than the Example 2-3 groups and significantly better than the positive control group ( # p<0.05; ##p<0.01). This result also shows that raw dragon bone and black-banded snake have a certain degree of influence on the anti-myocardial injury effect of the Chinese medicine composition of the present invention. When the dosage ratio of the above drugs in the formula is reduced, the anti-myocardial injury effect of the Chinese medicine composition of the present invention is slightly reduced.
[0090] The experimental results of Comparative Examples 1-2 show that changing the types of some raw materials in the traditional Chinese medicine composition of the present invention (see Comparative Example 1, in which the black-necked snake in Example 1 was replaced with a medicinal insect with similar efficacy to the black-necked snake) and subtracting some medicinal flavors of the traditional Chinese medicine composition of the present invention (see Comparative Example 2, in which one of the main medicines in Example 1, raw dragon bone, was subtracted) will lead to a significant reduction in the anti-myocardial injury effect of the traditional Chinese medicine composition of the present invention.
[0091] It can be seen that the types and dosage ratios of the raw materials used in the Chinese medicine composition of the present invention have a very significant effect on the anti-myocardial injury effect of the Chinese medicine composition of the present invention. Table 2: Effects of the Chinese medicine composition of the present invention on the expression of cTnT, CK-MB, and LDH in the aorta serum of rats with coronary heart disease
[0092] Effect of level (mean ± SD, n = 8)
[0093] Group c-TNT(pg / mL) CK-MB (ng / mL) LDH (ng / mL) Blank control group 0.224±0.106 0.162±0.048 61.19±9.47 Model Group 0.902±0.298 0.591±0.134 121.42±18.75 Positive control group <![CDATA[0.416±0.272 ** ]]> <![CDATA[0.364±0.138 * ]]> <![CDATA[83.54±12.38 *** ]]> Example 1 Group <![CDATA[0.325±0.181 ***,## ]]> <![CDATA[0.251±0.082 ***,## ]]> <![CDATA[70.83±9.98 ***,# ]]> Example 2 Group <![CDATA[0.348±0.192 ***,# ]]> <![CDATA[0.295±0.103 ** ]]> <![CDATA[72.69±9.54 ***,# ]]> Example 3 Group <![CDATA[0.342±0.197 ***,# ]]> <![CDATA[0.283±0.096 ***,# ]]> <![CDATA[73.58±9.25 ***,# ]]> Comparative Example 1 0.636±0.284 0.405±0.118 <![CDATA[98.06±10.37 * ]]> Comparative Example 2 <![CDATA[0.601±0.253 * ]]> 0.399±0.127 <![CDATA[95.29±9.46 * ]]>
[0094] Note: Compared with the model group, * p<0.05, ** p<0.01, *** p<0.001; compared with the positive control group, # p<0.05, ## p<0.01.
[0095] Obviously, those skilled in the art can make various changes and modifications to the present invention without departing from the spirit and scope of the present invention. Thus, if these modifications and variations of the present invention fall within the scope of the claims of the present invention and their equivalents, the present invention is also intended to include these modifications and variations.
Claims
1. A Chinese medicine composition for treating coronary heart disease and angina pectoris, characterized in that: The traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: 10-40 parts of ginseng, 10-40 parts of raw dragon bones, 5-30 parts of black snake, 5-30 parts of ophiopogon, 5-30 parts of red peony root, 5-30 parts of chuanxiong, 5-30 parts of pinellia, 5-20 parts of trichosanthes, 5-20 parts of xiebai, 5-20 parts of tuckahoe, 5-20 parts of coptis, and 1-10 parts of liquorice.
2. The Chinese medicine composition according to claim 1, characterized in that: The traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: 20-30 parts of ginseng, 20-30 parts of raw dragon bones, 5-20 parts of black snake, 5-20 parts of ophiopogon, 5-20 parts of red peony root, 5-20 parts of chuanxiong, 5-20 parts of pinellia, 5-15 parts of trichosanthes, 5-15 parts of allium macrostemon, 5-15 parts of tuckahoe, 5-15 parts of coptis root and 1-8 parts of liquorice.
3. The Chinese medicine composition according to claim 2, characterized in that: The Chinese medicine composition is prepared from the following raw materials in parts by weight: 24 parts of ginseng, 26 parts of raw dragon bones, 18 parts of black-necked snakes, 18 parts of ophiopogon japonicus, 18 parts of red peony root, 18 parts of ligusticum chuanxiong, 18 parts of pinellia tuber, 12 parts of trichosanthes, 12 parts of allium macrostemon, 12 parts of tuckahoe, 12 parts of coptis root, and 6 parts of liquorice.
4. The Chinese medicine composition according to claim 1, characterized in that: The Chinese medicine composition has the effects of warming yang and invigorating qi, resolving phlegm and activating blood circulation, and calming the heart and restoring pulse.
5. The method for preparing the Chinese medicine composition according to any one of claims 1 to 4, characterized in that: The preparation method comprises the following steps: crushing ginseng, raw dragon bone, black-banded snake, ophiopogon, red peony root, chuanxiong, pinellia tuber, trichosanthes, allium macrostemon, tuckahoe, coptis root and liquorice, adding water for decoction, mixing filtrate and concentrating to obtain concentrated solution.
6. The preparation method according to claim 5, characterized in that: The decoction is performed twice. After the first decoction for 1-3 hours, a primary filtrate is obtained by filtering. The filter residue is then decocted with water for 1-3 hours, and a secondary filtrate is obtained by filtering. The primary filtrate and the secondary filtrate are combined.
7. The preparation method according to claim 6, characterized in that: The material-liquid ratio of the first decoction and the second decoction is 1:4, the decoction time of the first decoction and the second decoction is 1.5 hours, and the water used in the first decoction and the second decoction is distilled water; preferably, the concentration is reduced pressure concentration.
8. Use of the Chinese medicine composition according to any one of claims 1 to 4 or the Chinese medicine composition prepared by the preparation method according to any one of claims 5 to 7 in preparing medicines for treating coronary heart disease and angina pectoris.
9. The use according to claim 8, characterized in that: The dosage form of the medicine is granules, tablets, oral liquid or capsules.
10. The use according to claim 9, characterized in that: The dosage form of the medicine is granules.
Citation Information
Patent Citations
Traditional Chinese medicine compound with effects of warming yang and benefiting heart
CN116077611A
Traditional Chinese medicine composition for treating coronary heart disease angina pectoris as well as preparation method and application of traditional Chinese medicine composition
CN116672404A
